Sure, sure. A simple drug delivery company playing in the same space as others. No great ability to attract lucrative royalty or force quick action from partners. The Suda offering is not sufficiently unique to guarantee success. There is upside, but the risk of no deal coming off is still significant.
I am surprised posters haven't noticed the lack of medicos or scientists on the threads about this company.
Perhaps it is approaching fair value now, it was certainly over inflated since the big rise (and chants of SUD SUD SUD in the day trader threads - a good week of that over there).
sud oversold, page-2
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.0¢ | $242.5K | 1.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1931 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 320094 | 5 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |